Risks of whole brain radiation therapy added to radiosurgery...
MD Anderson News Release 05/31/2015
Abstract LBA4
Whole Brain Radiation Therapy (WBRT) is associated with significantly worse...
Study identifies possible new combination chemotherapy for...
MD Anderson News Release 05/30/2015
For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced...
ASCO honors Allison for achievements in cancer immunotherapy
MD Anderson News Release 05/29/2015
The world’s leading organization of oncologists will honor Jim Allison, Ph.D., for his...
MD Anderson receives $9 million in CPRIT research funding
MD Anderson News Release 05/21/2015
The University of Texas MD Anderson Cancer Center has received more than $9 million in research...
Study Finds Biomarker May Boost Ovarian Cancer Chemotherapy...
MD Anderson News Release 05/20/2015
A molecule that helps control gene expression may play a role in controlling chemotherapy...
MD Anderson Making Cancer History® Seminar in Austin...
Experts to reveal latest knowledge in personalized therapy and cancer prevention at second annual, free lunch event
MD Anderson News...
Variations in liver cancer attributable to hepatitis virus...
Discovery that hepatitis B and C viruses generate markedly different clinical pathologies highlights potential change in treatment...
Stereotactic Ablative Radiotherapy achieves better overall...
First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an...
Protein FGL2 May Have Potential as Therapy Target for Brain...
MD Anderson News Release 05/13/2015
Blocking FGL2, a protein known to promote cancer, may offer a new strategy for treating brain...
Tumor sequencing study highlights benefits of profiling...
MD Anderson study identifies harmful inherited mutations; explores sharing this information with patients and families
MD Anderson...